David Malcom Rodman
Chief Medical Officer · Mineralys Therapeutics, Inc.
- 2024
- Aug 12, 2026
- 28
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Malcom Rodman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Jon Congleton - $15.64M in MLYS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $8.76M in MLYS purchases and sales in the last 12 months
- Adam Scott Levy - $5.36M in MLYS purchases and sales in the last 12 months
- Eric Warren - $3.30M in MLYS purchases and sales in the last 12 months
- Alexander M. Gold - $1.58M in MLYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Malcom Rodman?
David Malcom Rodman is a corporate insider, tracked as Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha holds 28 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Malcom Rodman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has David Malcom Rodman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 40 open-market sales ($6.06M) across all tracked filings.
